# Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib

> **NCT01475110** · — · COMPLETED · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 19 (actual)

## Conditions studied

- Chronic Myeloid Leukaemia

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT01475110
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-13
- **Primary completion:** 2016-11-24
- **Final completion:** 2016-11-24
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475110, "Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01475110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*